Diamyd Medical

Drug inspection FDA regulatory submission

FDA ends 14-month hold on one trial as it pauses another

A duo of insulin-related clinical trials are going in opposite directions, with the FDA lifting a 14-month clinical hold on one while pausing another.

Max Bayer Nov 28, 2022 10:40am